drugset / Trial / NCT03649750

Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted

NCT03649750

Phase 1 Completed 36 enrolled Reckitt Benckiser Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

Determine and compare the plasma concentrations of Mucinex® Extended Release (ER) 600 mg bi-layer tablet in normal healthy volunteers in fed and fasting conditions

Timeline

Start
2013-05-29
Primary completion
2013-08-07
Completion
2013-08-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaifenesin Small molecule 600 mg Oral

Indications

No indication recorded.